This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $188,482 to study the prevalence and effects of cannabidiol (CBD) use during pregnancy. The 5-year project, awarded on February 1, 2025, will be conducted by the University of Colorado-Denver to: Estimate the prevalence of CBD use by trimester among pregnant women receiving prenatal care at the university's clinics. Characterize the demographics,...
The federal Project Grant award R01DA057317, funded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859), will support research to investigate the effects of cannabinoid exposure on neurodevelopment and behavior. The $800,267 award, spanning from July 1, 2024 to May 31, 2029, will utilize a zebrafish model system to: 1) measure morphological and behavioral alterations in anxiety and locomotion; 2) assess...
This Project Grant award, valued at $376,078.00 and funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to explore the antecedents and consequences of cannabis use for coping purposes. The study will experimentally test whether cannabis use quantity increases after a stress induction among individuals who use cannabis to cope, as well as examine factors that may moderate this effect, such as social anxiety...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will provide $2,118,992 to the University of Miami to conduct research on the neural and psychiatric consequences of cannabis use in adolescents. The research will prospectively investigate the effects of cannabis, the most widely used illicit drug among teenagers, on reward and pain neurocircuits in adolescents with depression. The study aims to understand...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $350,000 in funding to Creighton University to conduct research on the developmental effects of environmental enrichment on minor cannabinoid drug reward and cannabinoid receptor levels. The research aims to investigate whether exposure to high- or low-novelty environments during adolescence can alter sensitivity to...
The federal Project Grant award F31DA060014 for $126,442 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The purpose of this grant is to investigate the effects of delta-9-tetrahydrocannabinol (THC) exposure during the third trimester of pregnancy on the development of the primary visual cortex in ferrets. The research aims to determine how prenatal THC exposure impacts the expression and function of cannabinoid type-1...
This $443,263 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund a 5-year study to characterize the effects of recreational cannabis use on sleep in women of childbearing age. The study will pair sleep behavior with nocturnal physiological measures of brain activity, stress reactivity, and autonomic nervous system function to delineate the proximal impacts of acute cannabis exposure across different...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $489,500.00 to The Children's Hospital Corporation (doing business as Boston Children's Hospital) to assess the feasibility of remotely evaluating cannabis non-use in younger adults through oral fluid testing. The project aims to establish the feasibility of remote testing for oral fluid delta-9-THC using video recordings and live observation,...
The National Institute on Drug Abuse (NIDA) awarded Brown University a $2,838,472 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a prospective mixed-methods investigation titled "Using Behavioral Economic Domains to Characterize Cannabis Use Trajectories Among Young Adults." This 5-year grant, effective July 15, 2024, aims to identify factors associated with hazardous cannabis use among young adults (ages 18-25), a critical developmental...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), totals $1,825,416 and has an award date of June 15, 2024. The award is funding research to develop and strengthen cannabis warning labels, with the goal of informing the public about the harms of cannabis use. The key objectives are to: 1) examine the legal and regulatory landscape of cannabis warning regulations in the U.S., 2) develop...